SITAGLO E (Empagliflozin (25mg) + Sitagliptin (100mg))

Sitaglo E 25/100 Tablet is indicated for the management of type 2 diabetes mellitus. This medication functions by assisting the kidneys in eliminating surplus glucose from the bloodstream while also enhancing the body’s insulin sensitivity, ultimately aiding in more effective blood sugar regulation. For optimal diabetes management, it should be integrated into a broader regimen that includes a balanced diet and regular physical activity. Adherence to your prescribed dosage of Sitaglo E 25/100 Tablet is crucial for maintaining stable blood glucose levels. Consistent intake not only maximizes the therapeutic effects of the medication but also minimizes the likelihood of severe complications associated with diabetes, such as neuropathy, nephropathy, and cardiovascular issues. It is important to continue the treatment even in the absence of symptoms, as diabetes is a chronic condition that necessitates ongoing management. If you experience any adverse effects or if your condition does not improve, it is essential to consult your healthcare provider, who may consider modifying your treatment plan or dosage. Prior to starting Sitaglo E 25/100 Tablet, inform your healthcare professional of any prior kidney or liver disorders, urinary tract infections, or cardiac issues. This medication is contraindicated for individuals with type 1 diabetes or those who have experienced diabetic ketoacidosis. Caution is advised in elderly patients or those who are dehydrated or taking diuretics, due to the potential risk of hypotension. Pregnant and breastfeeding individuals should seek medical guidance before commencing this treatment to ensure its safety.